The impact of midlife obesity on brain health and cognitive decline in older adults
Official title: Midlife Obesity, Neurovascular Senescence and Cognitive Decline
Funded at University of Oklahoma Hlth Sciences Ctr · NIH-10885976 · Data updated 2026-11-12
This study looks at how being overweight in middle age can impact brain health and memory as we get older, especially for people 65 and up, and it aims to find ways to help improve brain function through better lifestyle choices.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project start | August 1, 2021 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $120,156 |
| NIH project number | 5K01AG073614-04 |
| Project ID | NIH-10885976 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals aged 65 and older who are experiencing cognitive decline or have concerns about their brain health.
✕Less likely to help
Patients who are younger than 65 or do not have concerns related to cognitive decline may not benefit from this research.
What this research studies
This research investigates how obesity during midlife affects the aging brain and contributes to cognitive decline and dementia in individuals aged 65 and older. The study focuses on understanding the relationship between obesity and neurovascular health, utilizing advanced imaging techniques and nutritional interventions. By training in various methodologies, including biostatistics and single-cell analysis, the researcher aims to develop effective strategies to mitigate age-related cognitive impairments. Patients may benefit from insights into how lifestyle changes can improve brain health as they age.
Why it matters
Potential benefit: If successful, this research could lead to effective nutritional and lifestyle interventions that improve cognitive health in older adults.
How similar studies have gone: Previous research has shown promising results in using lifestyle interventions to improve cognitive outcomes in older adults, suggesting that this approach may be effective.
Where this research is happening
-
University of Oklahoma Hlth Sciences Ctr
Oklahoma City, United States Active
Researchers
- Principal investigator: Tarantini, Stefano — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Tarantini, Stefano
Related research
Other NIH-funded projects on the same topics.
-
Midlife obesity and prediabetes as triggers for later cognitive decline linked to immune dysregulation
This grant explores how midlife obesity and prediabetes may lead to memory and thinking problems later in life by influencing brain inflammation and immune pathways.
-
How midlife obesity and prediabetes affect brain health in older adults
This study is looking at how being overweight and having prediabetes in middle age might affect thinking and memory as we get older, especially by exploring how inflammation in the brain could play a role, and it aims to find ways to help prevent or slow down cognitive decline for older adults.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Understanding how maternal and infant sleep and daily rhythms influence early appetite and obesity risk
This project explores how infant sleep, circadian rhythms, and maternal-infant timing relate to early appetite patterns and the risk of obesity in the first year of life.
-
How COVID-19 infection and genes may influence memory and dementia risk
This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.
-
GLP-1 receptor agonists as immune targets to treat asthma in lean and obese adults
Aims to understand how GLP-1R‑agonist diabetes medicines may directly calm immune cells to reduce asthma in adults who are lean or obese.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.